- Fresenius Medical Care's (FMS) Q3 net profit +1.2% to $273M, beating forecasts of $268M, with earnings boosted by higher revenues per treatment in the U.S., the dialysis provider's most important market.
- Net revenue +7% to $3.67B vs consensus of $3.65B.
- Adjusted EPS +7% to $0.95.
- Fresenius expects FY net profit at the lower end of its forecast range of $1.1-1.15B, due to austerity in the U.S. Forecasts that revenue will grow over 6% to more than $14.6B. (PR)
Fresenius net profit edges up
Nov 5 2013, 02:38 ET